Effectiveness of Intraoperative Neuromonitoring of External Branch of Superior Laryngeal Nerve in Thyroid Surgery

Sponsor
Seoul National University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT06002984
Collaborator
(none)
94
1
2
28
3.4

Study Details

Study Description

Brief Summary

The frequent occurrence of impaired function in the external branch of the superior laryngeal nerves following thyroid surgery is recognized as a prevalent complication leading to a diminished quality of life. The objective of this randomized controlled trial (RCT) is to assess the efficacy of neuromonitoring during thyroid surgery in order to safeguard the integrity of these nerves.

Condition or Disease Intervention/Treatment Phase
  • Device: Using Neuromonitoring to find EBSLN
N/A

Detailed Description

With increased interest in quality of life after thyroidectomy, preservation of proper vocal cord function and voice quality is an important issue in thyroid surgery. External branch of the superior laryngeal nerve (EBSLN) and recurrent laryngeal nerve (RLN) are crucial organs for innervation and integration of laryngeal muscular system. The EBSLN innervates the cricothyroid muscle (CTM), which is important in adjusting the tension and length of the vocal cords. Damage of the EBSLN leads to CTM dysfunction, resulting in difficulty with high pitch phonation and decreased pitch range and reduced voice projection, which are important for voice professionals. As the intraoperative neuromonitoring was utilized as an adjunctive and objective tool to confirm the nerve presence and integrity, application of the intraoperative neuromonitoring system to confirm EBSLN function pre- and post-dissection of the upper thyroid pole can be regarded as an effective method to preserve cricothyroid muscle function. However, it remains unclear whether there is any intraoperative neuromonitoring techniques-added value to the clinical outcome of thyroidectomy in terms of identification of EBSLN and preserved voice performance. Therefore, this study could provide strong evidence of the application of the intraoperative neuromonitoring during thyroid surgery to identify and preserve EBSLN function.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
94 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Effectiveness of Intraoperative Neuromonitoring to Identify and Preserve External Branch of Superior Laryngeal Nerve During Thyroid Surgery
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Jun 30, 2025
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Using neuromonitoring to find EBSLN

With neuromonitoring of the EBSLN using nerve monitoring system Intervention Device: Neuromonitoring to find EBSLN

Device: Using Neuromonitoring to find EBSLN
intraoperative neuromonitoring to preserving external branch of superior laryngeal nerve during thyroid surgery

No Intervention: No using neuromonitoring to find EBSLN

Without neuromonitoring of the EBSLN using nerve monitoring system

Outcome Measures

Primary Outcome Measures

  1. Identification rate of EBSLN [during operation]

    Visual identification rate, Electrostimulatory identification rate

Secondary Outcome Measures

  1. Change of results about questionnaire for quality of voice [up to postoperative 1 month, 3 months and 6 months]

    Voice Handicap Index-10

  2. Changes of Vocal outcome [up to postoperative 1 month, 3 months and 6 months]

    Visual Analogue Scales (VAS)

  3. Measurements of Vocal function [up to postoperative 1 month, 3 months and 6 months]

    Maximum Phonation Time (MPT)

  4. Vocal evaluation [up to postoperative 1 month, 3 months and 6 months]

    GRBAS (Grade, Rough, Breathy, Asthenia, and Strain)

  5. Changes of Vocal fold vibration patterns [up to postoperative 1 month, 3 months and 6 months]

    EGG (electroglottography) assessment of voice

  6. Changes of Vocal outcome by Computerized Acoustic Analysis [up to postoperative 1 month, 3 months and 6 months]

    Multi-Dimensional Voice Program (MDVP)

  7. Changes of Voice Pitch [up to postoperative 1 month, 3 months and 6 months]

    Real-time pitch (RTP)

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 79 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who are scheduled to undergo thyroid surgery

  • Patients who understand and agree to take part in this study

Exclusion Criteria:
  • If the thyroid tumor is suspected to invade adjacent organs (esophagus, trachea, carotid artery, jugular vein etc.)

  • Patients who are required with lateral compartment neck dissection

  • Patients with recurrent thyroid cancer

  • Patients with palsy of recurrent laryngeal nerve or superior laryngeal nerve external branch in the past or present

  • Patients with a history of vocal cord and larynx disease

  • History of hyperthyroidism (e.g., Graves' disease)

  • Taking anticoagulants (aspirin, warfarin, etc.) before surgery

  • Disorders of coagulation

  • In the case of women, pregnant women and breastfeeding patients

  • Patients judged inappropriate by clinical trial researcher

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Hospital Seoul Korea, Republic of

Sponsors and Collaborators

  • Seoul National University Hospital

Investigators

  • Principal Investigator: Su-Jin Kim, M.D, Ph.D, Seoul National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Su-jin Kim, Associate Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT06002984
Other Study ID Numbers:
  • 2303-075-1411
First Posted:
Aug 21, 2023
Last Update Posted:
Aug 21, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Su-jin Kim, Associate Professor, Seoul National University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 21, 2023